Polysomnographic characteristics in patients with mucopolysaccharidoses

Pediatric Pulmonology

Volumn 45, Issue 12, 2010, Pages 1205-1212

  Lin, Hsiang Yu ^a,b,c   Chen, Ming Ren ^a,c   Lin, Ching Chi ^a,c   Chen, Chih Ping ^a   Lin, Dar Shong ^a,c   Chuang, Chih Kuang ^a,d,e   Niu, Dau Ming ^b,f   Chang, Jui Hung ^g   Lee, Hung Chang ^a,h   Lin, Shuan Pei ^a,c,i  

^a MACKAY MEMORIAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c NURSING AND MANAGEMENT COLLEGE   (Taiwan)

^d FU JEN CATHOLIC UNIVERSITY   (Taiwan)

^e NATIONAL TAIPEI UNIVERSITY OF TECHNOLOGY   (Taiwan)

^f TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^g CHANG GUNG UNIVERSITY   (Taiwan)

^h TAIPEI MEDICAL UNIVERSITY   (Taiwan)

ⁱ NATIONAL TAIPEI UNIVERSITY OF NURSING AND HEALTH SCIENCES   (Taiwan)

Author keywords

enzyme replacement therapy; glycosaminoglycans; obstructive; sleep apnea

Indexed keywords

ADOLESCENT; ADULT; APNEA INDEX; ARTERIAL OXYGEN SATURATION; ARTICLE; BREATHING; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME REPLACEMENT; FEMALE; HUMAN; HYPOPNEA INDEX; MALE; MUCOPOLYSACCHARIDOSIS; POLYSOMNOGRAPHY; PRIORITY JOURNAL; SLEEP; SLEEP APNEA SYNDROME;

ADOLESCENT; ADULT; AGE FACTORS; CHILD; CHILD, PRESCHOOL; ENZYME REPLACEMENT THERAPY; FEMALE; HUMANS; MALE; MUCOPOLYSACCHARIDOSES; OXYGEN; POLYSOMNOGRAPHY; PUBERTY; SEVERITY OF ILLNESS INDEX; SLEEP APNEA, OBSTRUCTIVE; YOUNG ADULT;

EID: 78649653058     PISSN: 87556863     EISSN: 10990496     Source Type: Journal    
DOI: 10.1002/ppul.21309     Document Type: Article

References (31)

1. Neufeld EF, Muenzer J,. The mucopolysaccharidoses. In:, Scriver CR, Beaudet AL, Sly WS, Valle D, editors;, Childs B, Kinzler KW, Vogelstein B, assoc. editors. The metabolic and molecular bases of inherited disease, 8th edition. New York: McGraw-Hill; 2001. pp 3421-3452.
2. Chuang CK, Lin SP,. Neurochemical changes and therapeutical approaches in mucopolysaccharidoses. In:, Sankar S, Michael A, Maheep B, editors. Neurochemistry of metabolic diseases-lysosomal storage diseases, phenylketouria and Canavan disease. Trivandrum, Kerala, India: Transworld Research Network; 2007. pp 1-20.
3. Lin HY, Lin SP, Chuang CK, Niu DM, Chen MR, Tsai FJ, Chao MC, Chiu PC, Lin SJ, Tsai LP, Hwu WL, Lin JL,. Incidence of the mucopolysaccharidoses in Taiwan, 1984-2004. Am J Med Genet A 2009; 149A: 960-964.
4. Nashed A, Al-Saleh S, Gibbons J, MacLusky I, MacFarlane J, Riekstins A, Clarke J, Narang I,. Sleep-related breathing in children with mucopolysaccharidosis. J Inherit Metab Dis 2009; 32: 544-550.
5. Santamaria F, Andreucci MV, Parenti G, Polverino M, Viggiano D, Montella S, Cesaro A, Ciccarelli R, Capaldo B, Andria G,. Upper airway obstructive disease in mucopolysaccharidoses: polysomnography, computed tomography and nasal endoscopy findings. J Inherit Metab Dis 2007; 30: 743-749.
6. Leighton SE, Papsin B, Vellodi A, Dinwiddie R, Lane R,. Disordered breathing during sleep in patients with mucopolysaccharidoses. Int J Pediatr Otorhinolaryngol 2001; 58: 127-138.
7. Muenzer J, Wraith JE, Clarke LA, International Consensus Panel on the Management and Treatment of Mucopolysaccharidosis I. Mucopolysaccharidosis I: Management and Treatment Guidelines. Pediatrics 2009; 123: 19-29.
8. Wraith JE,. The first 5 years of clinical experience with laronidase enzyme replacement therapy for mucopolysaccharidosis I. Expert Opin Pharmacother 2005; 6: 489-506.
9. Chuang CK, Lin SP, Chung SF,. Diagnostic screening for mucopolysaccharidoses by the dimethylmethylene blue method and two dimensional electrophoresis. Zhonghua Yi Xue Za Zhi (Taipei) 2001; 64: 15-22.
10. Lin SP, Chang JH, Lee-Chen GJ, Lin DS, Lin HY, Chuang CK,. Detection of Hunter syndrome (mucopolysaccharidosis type II) in Taiwanese: biochemical and linkage studies of the iduronate-2-sulfatase gene defects in MPS II patients and carriers. Clin Chim Acta 2006; 369: 29-34.
11. Lin HY, Lin SP, Lin CC, Tsai LP, Chen MR, Chuang CK, Huang CY,. Polysomnographic characteristics in patients with Prader-Willi syndrome. Pediatr Pulmonol 2007; 42: 881-887.
12. Rechtschaffen A, Kales A,. A manual of standardized terminology, techniques and scoring systems for sleep stages on human subjects. Publication no. 204. Washington, DC: National Institutes of Health; 1968.
13. Iber C, Ancoli-Israel S, Chesson AL, Jr., Quan SF,. The AASM manual for the scoring of sleep and associated events: rules, terminology and technical specifications. Westchester, IL: American Academy of Sleep Medicine; 2007.
14. Atlas Task Force. Recording and scoring leg movements. Sleep 1993; 16: 748-759.
15. EEG Arousals. Scoring rules and examples. A preliminary report from the Sleep Disorders Atlas Task Force of the American Sleep Disorders Association. Sleep 1992; 15: 173-184.
16. Verhulst SL, Schrauwen N, Haentjens D, Van Gaal L, De Backer WA, Desager KN,. Reference values for sleep-related respiratory variables in asymptomatic European children and adolescents. Pediatr Pulmonol 2007; 42: 159-167.
17. Montgomery-Downs HE, O'Brien LM, Gulliver TE, Gozal D,. Polysomnographic characteristics in normal preschool and early school-aged children. Pediatrics 2006; 117: 741-753.
18. Traeger N, Schultz B, Pollock AN, Mason T, Marcus CL, Arens R,. Polysomnographic values in children 2-9 years old: additional data and review of the literature. Pediatr Pulmonol 2005; 40: 22-30.
19. Uliel S, Tauman R, Greenfeld M, Sivan Y,. Normal polysomnographic respiratory values in children and adolescents. Chest 2004; 125: 872-878.
20. Jones SA, Almássy Z, Beck M, Burt K, Clarke JT, Giugliani R, Hendriksz C, Kroepfl T, Lavery L, Lin SP, Malm G, Ramaswami U, Tincheva R, Wraith JE, HOS Investigators. Mortality and cause of death in mucopolysaccharidosis type II-a historical review based on data from the Hunter Outcome Survey (HOS). J Inherit Metab Dis 2009; 32: 534-543.
21. Rao A, Tey BH, Ramalingam G, Poh AG,. Obstructive sleep apnoea (OSA) patterns in bariatric surgical practice and response of OSA to weight loss after laparoscopic adjustable gastric banding (LAGB). Ann Acad Med Singapore 2009; 38: 587-593.
22. Villaneuva AT, Buchanan PR, Yee BJ, Grunstein RR,. Ethnicity and obstructive sleep apnoea. Sleep Med Rev 2005; 9: 419-436.
23. Ong KC, Clerk AA,. Comparison of the severity of sleep-disordered breathing in Asian and Caucasian patients seen at a sleep disorders center. Respir Med 1998; 92: 843-848.
24. Semenza GL, Pyeritz RE,. Respiratory complications of mucopolysaccharide storage disorders. Medicine (Baltimore) 1988; 67: 209-219.
25. Shih SL, Lee YJ, Lin SP, Sheu CY, Blickman JG,. Airway changes in children with mucopolysaccharidoses. Acta Radiol 2002; 43: 40-43.
26. Harmatz P, Giugliani R, Schwartz IV, Guffon N, Teles EL, Miranda MC, Wraith JE, Beck M, Arash L, Scarpa M, Ketteridge D, Hopwood JJ, Plecko B, Steiner R, Whitley CB, Kaplan P, Yu ZF, Swiedler SJ, Decker C, MPS VI Study Group. Long-term follow-up of endurance and safety outcomes during enzyme replacement therapy for mucopolysaccharidosis VI: final results of three clinical studies of recombinant human N-acetylgalactosamine 4-sulfatase. Mol Genet Metab 2008; 94: 469-475.
27. Wraith JE, Scarpa M, Beck M, Bodamer OA, De Meirleir L, Guffon N, Meldgaard Lund A, Malm G, Van der Ploeg AT, Zeman J,. Mucopolysaccharidosis type II (Hunter syndrome): a clinical review and recommendations for treatment in the era of enzyme replacement therapy. Eur J Pediatr 2008; 167: 267-277.
28. Lin HY, Lin SP, Chuang CK, Chen MR, Chen BF, Wraith JE,. Mucopolysaccharidosis I under enzyme replacement therapy with laronidase-a mortality case with autopsy report. J Inherit Metab Dis 2005; 28: 1146-1148.
29. Wraith JE, Clarke LA, Beck M, Kolodny EH, Pastores GM, Muenzer J, Rapoport DM, Berger KI, Swiedler SJ, Kakkis ED, Braakman T, Chadbourne E, Walton-Bowen K, Cox GF,. Enzyme replacement therapy for mucopolysaccharidosis I: a randomized, double-blinded, placebo-controlled, multinational study of recombinant human alpha-L-iduronidase (laronidase). J Pediatr 2004; 144: 581-588.
30. Sifuentes M, Doroshow R, Hoft R, Mason G, Walot I, Diament M, Okazaki S, Huff K, Cox GF, Swiedler SJ, Kakkis ED,. A follow-up study of MPS I patients treated with laronidase enzyme replacement therapy for 6 years. Mol Genet Metab 2007; 90: 171-180.
31. Kakkis ED, Muenzer J, Tiller GE, Waber L, Belmont J, Passage M, Izykowski B, Phillips J, Doroshow R, Walot I, Hoft R, Neufeld EF,. Enzyme-replacement therapy in mucopolysaccharidosis I. N Engl J Med 2001; 344: 182-188.